コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 solution, and remarkable NIR-II image-guided photothermal therapy.
2 or image-guided interventions and augmenting photothermal therapy.
3 tercellular cohesion of the epidermis during photothermal therapy.
4 aging-guided synergistic starvation-enhanced photothermal therapy.
5 e the utility of these nanorods for in vitro photothermal therapy.
6 s so generated were used as active agents in photothermal therapy.
7 sing, biological imaging, drug delivery, and photothermal therapy.
8 ell to enable both photoacoustic imaging and photothermal therapy.
9 adsorption/separation, catalysis, and chemo-photothermal therapy.
10 is completely eliminated with combined chemo-photothermal therapy.
11 ic resonance (MR) imaging, gene-delivery and photothermal therapy.
12 veloped with limited success for tumor chemo-photothermal therapy.
13 erved, which allowed for efficient plasmonic photothermal therapy.
14 under preclinical settings, and as a type of photothermal therapy.
15 f SERS agents for targeted drug delivery and photothermal therapy.
16 bsorbance and biocompatibility for potential photothermal therapy.
17 d via highly effective long wavelength light photothermal therapy.
18 rom the endogenous signal to guide effective photothermal therapy.
19 g mice through treatment with MTyr-OANPs and photothermal therapy.
20 hey could be applied as a robust platform in photothermal therapy.
21 ng cancer cells compared to single chemo- or photothermal therapies.
23 strategy for mitigating the side effects of photothermal therapy against a wide spectrum of bacteria
24 animal levels compared with chemotherapy or photothermal therapy alone, indicating the PEG-OJNP-LA c
26 chemotherapy and enables the combination of photothermal therapy and chemotherapy to receive superio
27 herapeutics, including photodynamic therapy, photothermal therapy and light-triggered drug delivery,
30 synergistic interaction between CuS-mediated photothermal therapy and porphyrin-mediated photodynamic
31 al characteristics to destroy tumors through photothermal therapy and rationally designed nanostructu
32 d nanostructure based in vivo bioimaging and photothermal therapy and their loading capacity for both
33 hotothermal multimodal-imaging-guided cancer photothermal therapy and UV and gamma-irradiation protec
34 owerful potential tools for in vivo imaging, photothermal therapy, and drug delivery thanks to plasmo
35 ts in various bioimaging modalities, near-IR photothermal therapy, and for light-triggered therapeuti
36 induced via gold nanorod mediated plasmonic photothermal therapy, and intravenous administration of
37 roscopy, superresolution optical microscopy, photothermal therapy, and long-distance telecommunicatio
39 herapeutic approaches (i.e. drug delivery or photothermal therapy), are also included in this overvie
40 heat upon irradiation are being explored for photothermal therapy as a minimally invasive approach to
41 distinct from both photodynamic therapy and photothermal therapy as its mechanical effect on the cel
42 Gold nanorods (AuNRs)-assisted plasmonic photothermal therapy (AuNRs-PPTT) is a promising strateg
43 thermal contrast agents are not required for photothermal therapy but can enhance the efficiency and
44 underlined, that it is the first example of photothermal therapy carried out in a microsystem on mul
45 frared (NIR) light-assisted nanoparticles in photothermal therapy, chemotherapy, and photodynamic the
46 thermal destruction of cancer in the case of photothermal therapy due to their photothermal heating p
52 y in photonic applications and potential for photothermal therapy, its photobleaching hinders its app
53 ed to investigate the prostate tumor uptake, photothermal therapy mediated macromolecular delivery, a
55 For cancer therapy in mice, tumor PS and photothermal therapy of anti-CD11b Abs-linked gold nanor
57 ional ~150nm silica core gold nanoshells for photothermal therapy of triple negative breast cancer.
58 n cancer therapy for drug and gene delivery, photothermal therapy, overcoming chemotherapy resistance
59 (NIR)-triggered photodynamic-photocatalytic-photothermal therapy (PDT-PCT-PTT) agent based on an ato
60 red and photoacoustic imaging and synergetic photothermal therapy/photodynamic therapy derived from t
61 oparticles have great potential in plasmonic photothermal therapy (photothermolysis), but their intra
63 n that gold nanorod (GNR) mediated plasmonic photothermal therapy (PPTT) is capable of increasing the
65 ar-infrared (NIR) light to generate heat for photothermal therapy (PPTT), where the temperature was a
67 The AuPC in tumors were also employed as a photothermal therapy (PTT) agent to uniformly heat up an
68 serve as robust near-infrared (NIR)-mediated photothermal therapy (PTT) agents owing to their efficie
70 The ablation of tumors with high-intensity photothermal therapy (PTT) by near-infrared (NIR) irradi
74 use of photothermal agents (PTAs) in cancer photothermal therapy (PTT) has shown promising results i
76 esides, other treatment strategies including photothermal therapy (PTT) have been combined with MN ar
79 al manipulation, imaging, drug delivery, and photothermal therapy (PTT) of cancerous cells based on t
80 e-enabled fluorescence-guided transbronchial photothermal therapy (PTT) of peripheral lung cancer was
83 ies including photodynamic therapy (PDT) and photothermal therapy (PTT) to treat many diseases, and h
85 e developed a dual-action strategy combining photothermal therapy (PTT) using gold-decorated iron oxi
88 tly convert light to heat inside tumours for photothermal therapy (PTT), and light to singlet oxygen
90 modal cancer treatment strategy by combining photothermal therapy (PTT), gas therapy (GT), and immuno
91 been widely studied in cancer detection and photothermal therapy (PTT), while it remains a great cha
97 iative conversion of light energy into heat (photothermal therapy, PTT) or sound energy (photoacousti
99 ation has potential in photodynamic therapy, photothermal therapy, radiotherapy, protected delivery o
101 demonstrated utility in cancer diagnostics, photothermal therapy, targeted drug delivery, biosensing
102 rate information needed for optimization of photothermal therapy that invokes infrared irradiation t
103 applications in, for example, nanoantennas, photothermal therapy, thermophotovoltaics, catalysis, se
104 elanin as a natural photothermal reagent for photothermal therapy, we demonstrated the complete eradi
105 n and plasmonic gold nanostar (GNS)-mediated photothermal therapy, we were able to achieve complete e
106 d chemical damage in the target lesions, and photothermal therapy, which results in localized thermal
107 s reduced tumor burden in a single course of photothermal therapy while coupling three complementary
108 vehicles are constructed for combined chemo-photothermal therapy with pinpointed drug delivery and r
109 that our theranostics platform, integrating photothermal therapy without drugs or other chemicals, c